228 related articles for article (PubMed ID: 34658294)
21. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma.
Ding H; Cui L; Wang C
Neurol Res; 2021 Mar; 43(3):210-219. PubMed ID: 33070767
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
24. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K
Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366
[TBL] [Abstract][Full Text] [Related]
25. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway.
Hu Y; Zhang Y; Ding M; Xu R
J Gastroenterol Hepatol; 2021 Jul; 36(7):1877-1888. PubMed ID: 33295056
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA HAND2-AS1 delays cervical cancer progression via its regulation on the microRNA-21-5p/TIMP3/VEGFA axis.
Gao Y; Zou T; Liang W; Zhang Z; Qie M
Cancer Gene Ther; 2021 Jun; 28(6):619-633. PubMed ID: 33139818
[TBL] [Abstract][Full Text] [Related]
28. lncRNA LIFR-AS1 suppresses invasion and metastasis of non-small cell lung cancer via the miR-942-5p/ZNF471 axis.
Wang Q; Wu J; Huang H; Jiang Y; Huang Y; Fang H; Zheng G; Zhou X; Wu Y; Lei C; Hu D
Cancer Cell Int; 2020; 20():180. PubMed ID: 32489316
[TBL] [Abstract][Full Text] [Related]
29. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.
Xu F; Li H; Hu C
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31127025
[TBL] [Abstract][Full Text] [Related]
30. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
31. The N
Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H
Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628
[No Abstract] [Full Text] [Related]
32. Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis.
Liu Y; Chen S; Cai K; Zheng D; Zhu C; Li L; Wang F; He Z; Yu C; Sun C
Cell Death Dis; 2022 Mar; 13(3):232. PubMed ID: 35283481
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of LOXL1-AS1 alleviates oxidative low-density lipoprotein induced angiogenesis via downregulation of miR-590-5p mediated KLF6/VEGF signaling pathway.
Cheng X; Liu Z; Zhang H; Lian Y
Cell Cycle; 2021 Sep; 20(17):1663-1680. PubMed ID: 34334119
[TBL] [Abstract][Full Text] [Related]
34. Long Noncoding RNA LIFR-AS1: A New Player in Human Cancers.
Bai Z; Wang X; Zhang Z
Biomed Res Int; 2022; 2022():1590815. PubMed ID: 35071590
[TBL] [Abstract][Full Text] [Related]
35. LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinoma.
Shi C; Yang Q; Pan S; Lin X; Xu G; Luo Y; Zheng B; Xie X; Yu M
Cancer Biol Ther; 2020 Jul; 21(7):604-614. PubMed ID: 32329664
[TBL] [Abstract][Full Text] [Related]
36. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
37. CERS6-AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR-195-5p/WIPI2 axis.
Gao KF; Zhao YF; Liao WJ; Xu GL; Zhang JD
Kaohsiung J Med Sci; 2022 Jun; 38(6):542-553. PubMed ID: 35199935
[TBL] [Abstract][Full Text] [Related]
38. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
39. LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.
Geng S; Tu S; Fu W; Wang J; Bai Z
Cell Cycle; 2021 Oct; 20(19):1988-1998. PubMed ID: 34470587
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis.
Huang X; Wang Z; Hou S; Yue C; Li Z; Hu W; Lu H
Bioengineered; 2022 Feb; 13(2):4153-4165. PubMed ID: 35142595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
